NasdaqCM - Nasdaq Real Time Price USD

Inotiv, Inc. (NOTV)

1.8518

-0.0682

(-3.52%)

As of 12:35:17 PM EDT. Market Open.

Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025

WEST LAFAYETTE, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that it will issue its financial results for the fiscal 2025 second quarter ended March 31, 2025, on Wednesday, May 7, 2025, after the close of the stock market. The Company will host a conf

GlobeNewswire yesterday

NOTV
-3.52%
Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders

Sea's pre-clinical stage neurotherapeutic synthetic oral molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the CNS (central nervous system) Sea's lead molecule SPM-0404 is a potential new oral treatment ...

ACCESS Newswire 18 days ago

NOTV
-3.52%
Inotiv (NASDAQ:NOTV investor three-year losses grow to 88% as the stock sheds US$46m this past week

Every investor on earth makes bad calls sometimes. But you want to avoid the really big losses like the plague. So take...

Simply Wall St. last month

NOTV
-3.52%
Inotiv Inc (NOTV) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth ...

Despite a revenue dip, Inotiv Inc (NOTV) focuses on liquidity improvement, client base expansion, and strategic investments for future growth.

GuruFocus.com 2 months ago

NOTV
-3.52%
Inotiv Reports First Quarter Financial Results for Fiscal 2025 and Provides Business Update

Enhanced liquidity by $27.5 million through the issuance of 6.9 million common sharesFirst quarter fiscal 2025 revenue declined 11.5% to $119.9 millionConference call scheduled for today at 4:30 pm ET WEST LAFAYETTE, Ind., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced fin

GlobeNewswire 2 months ago

NOTV
-3.52%
Inotiv, Inc. to Report Fiscal 2025 First Quarter Financial Results and Host Conference Call on Wednesday, February 5, 2025

WEST LAFAYETTE, Ind., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that it will issue its financial results for the fiscal 2025 first quarter ended December 31, 2024, on Wednesday, February 5, 2025, after the close of the stock market. The Company will host

GlobeNewswire 2 months ago

NOTV
-3.52%
Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $3.6 Million

WEST LAFAYETTE, Ind., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that it had raised an additional $3.6 million in net proceeds from the optional shares in connection with its previously announced underwritten public offering of common shares. The Company issued the add

GlobeNewswire 3 months ago

NOTV
-3.52%
Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $24.0 Million

WEST LAFAYETTE, Ind., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that it had raised approximately $24.0 million in net proceeds from its underwritten public offering of 6,000,000 common shares at a price to the public of $4.25 per share. All the shares were offered and

GlobeNewswire 3 months ago

NOTV
-3.52%
Inotiv, Inc. Announces Pricing of Public Offering of 6,000,000 Common Shares

WEST LAFAYETTE, Ind., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced the pricing of its underwritten public offering of 6,000,000 common shares at a price to the public of $4.25 per share. In addition, the Company has granted the underwriter a 30-day option to purchase up

GlobeNewswire 4 months ago

NOTV
-3.52%
Inotiv, Inc. Launches Proposed Public Offering of Common Shares

WEST LAFAYETTE, Ind., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced commencement of a proposed underwritten public offering of its common shares. All the shares will be offered by the Company. The Company also expects to grant the underwriters a 30-day option to purchase

GlobeNewswire 4 months ago

NOTV
-3.52%
Inotiv Inc (NOTV) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Operational Challenges

Inotiv Inc (NOTV) reports a 23% quarter-over-quarter revenue increase despite facing a net loss and pricing pressures.

GuruFocus.com 4 months ago

NOTV
-3.52%
Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2024 and Provides Business Update

— Enhanced liquidity through issuance of Second Lien Notes — Obtained amendment to credit agreement and extended note payable — Fourth quarter fiscal 2024 revenue down 7.3% to $130.4 million — Full year fiscal 2024 revenue down 14.3% to $490.7 million — Conference call begins today at 4:30 pm ET WEST LAFAYETTE, Ind., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and

GlobeNewswire 4 months ago

NOTV
-3.52%
Inotiv Ranked Number 138 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

Acquiring and Developing Services and Resources to Build a Full Service, Customer-Focused CRO has Fueled 847% Revenue GrowthWEST LAFAYETTE, Ind., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Inotiv today announced it ranked 138 on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America. Over the last five years Inotiv grew 847%. Inotiv’s president and chief executive officer, Robert Lea

GlobeNewswire 5 months ago

NOTV
-3.52%
Inotiv, Inc. to Report Fiscal 2024 Fourth Quarter and Full Year Results and Host Conference Call on Tuesday, December 3, 2024

WEST LAFAYETTE, Ind., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that it will issue its financial results for the fiscal 2024 fourth quarter and full year ended September 30, 2024, on Tuesday, December 3, 2024, after the close of the stock market. The Compa

GlobeNewswire 5 months ago

NOTV
-3.52%
Inotiv, Inc. to Participate in Upcoming Jefferies and Craig-Hallum Investor Conferences

WEST LAFAYETTE, Ind., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that Robert Leasure Jr., President and Chief Executive Officer, will present at the upcoming Jefferies London Global Healthcare Conference. Beth Taylor, Chief Financial Officer, will participa

GlobeNewswire 5 months ago

NOTV
-3.52%
Inotiv Inc (NOTV) Q3 2024 Earnings Call Highlights: Navigating Revenue Declines and Strategic ...

Despite significant revenue drops, Inotiv Inc (NOTV) focuses on strategic initiatives and legal resolutions to stabilize future growth.

GuruFocus.com 6 months ago

NOTV
-3.52%
Inotiv, Inc. Amends Its Credit Agreement and Secures Additional Liquidity

WEST LAFAYETTE, Ind., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, has amended certain terms of its Credit Agreement. In addition, Inotiv has closed the sale of $22.6 million aggregate principal amount of 15% Senior Secured Second Lien PIK Notes due February 2027 (the “Seco

GlobeNewswire 7 months ago

NOTV
-3.52%
Inotiv to Participate in the 8th Annual Lake Street Best Ideas Growth Conference

WEST LAFAYETTE, Ind., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today that Robert Leasure Jr., Inotiv’s President and Chief Executive Officer, and Beth Taylor, Chief Financial Officer, will participate in the 8th Annual Lake Street Best Ideas Growth Conference on Thursday, September 12, 20

GlobeNewswire 7 months ago

NOTV
-3.52%
Inotiv Third Quarter 2024 Earnings: Misses Expectations

Inotiv ( NASDAQ:NOTV ) Third Quarter 2024 Results Key Financial Results Revenue: US$105.8m (down 33% from 3Q 2023). Net...

Simply Wall St. 8 months ago

NOTV
-3.52%
Inotiv, Inc. (NOTV) Reports Q3 Loss, Lags Revenue Estimates

Inotiv (NOTV) delivered earnings and revenue surprises of -122.22% and 14.51%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 8 months ago

NOTV
-3.52%

Performance Overview

Return	NOTV	S&P 500 (^GSPC)
YTD	-55.27%	-6.40%
1-Year	-56.83%	+9.04%
3-Year	-91.04%	+28.14%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Inotiv, Inc. (NOTV)

Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025

Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders

Inotiv (NASDAQ:NOTV investor three-year losses grow to 88% as the stock sheds US$46m this past week

Inotiv Inc (NOTV) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth ...

Inotiv Reports First Quarter Financial Results for Fiscal 2025 and Provides Business Update

Inotiv, Inc. to Report Fiscal 2025 First Quarter Financial Results and Host Conference Call on Wednesday, February 5, 2025

Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $3.6 Million

Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $24.0 Million

Inotiv, Inc. Announces Pricing of Public Offering of 6,000,000 Common Shares

Inotiv, Inc. Launches Proposed Public Offering of Common Shares

Inotiv Inc (NOTV) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Operational Challenges

Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2024 and Provides Business Update

Inotiv Ranked Number 138 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

Inotiv, Inc. to Report Fiscal 2024 Fourth Quarter and Full Year Results and Host Conference Call on Tuesday, December 3, 2024

Inotiv, Inc. to Participate in Upcoming Jefferies and Craig-Hallum Investor Conferences

Inotiv Inc (NOTV) Q3 2024 Earnings Call Highlights: Navigating Revenue Declines and Strategic ...

Inotiv, Inc. Amends Its Credit Agreement and Secures Additional Liquidity

Inotiv to Participate in the 8th Annual Lake Street Best Ideas Growth Conference

Inotiv Third Quarter 2024 Earnings: Misses Expectations

Inotiv, Inc. (NOTV) Reports Q3 Loss, Lags Revenue Estimates

Performance Overview